Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 14, 2022
Long-term efficacy (up to 68 weeks) of Baricitinib in combination with topical corticosteroids in adult patients with moderate-to-severe atopic dermatitis: Analysis of treatment responders, partial responders and nonresponders originating from study BREEZE-AD7Jonathan I Silverberg, Eric L Simpson, Jacob Pontoppidan Thyssen, et al.Advanced Materials (Deerfield Beach, Fla.)|March 27, 2025
A Natural Lignification Inspired Super-Hard Wood-Based Composites with Extreme ResilienceYuxiang Huang, Kaixin Jiang, Yingqi He, et al.Dermatology and Therapy|June 26, 2024
Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic DermatitisPeter A Lio, April Armstrong, Jan Gutermuth, et al.The Journal of Dermatological Treatment|May 12, 2024
Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trialsAdelaide A Hebert, Carsten Flohr, H Chih-Ho Hong, et al.The Patient|February 3, 2018
Patient and Family Advisory Councils (PFACs): Identifying Challenges and Solutions to Support Engagement in ResearchJames D Harrison, Wendy G Anderson, Maureen Fagan, et al.The Journal of Nursing Administration|September 7, 2019
Patient and Family Advisory Councils for Research: Recruiting and Supporting Members From Diverse and Hard-to-Reach CommunitiesJames D Harrison, Wendy G Anderson, Maureen Fagan, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 3, 2017
Use of white matter reference regions for detection of change in florbetapir positron emission tomography from completed phase 3 solanezumab trialsAdam S Fleisher, Abhinay D Joshi, Karen L Sundell, et al.MMWR. Morbidity and Mortality Weekly Report|November 16, 2023
Vital Signs: Missed Opportunities for Preventing Congenital Syphilis - United States, 2022Robert McDonald, Kevin O'Callaghan, Elizabeth Torrone, et al.Pageof 2